Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03235193 · ClinicalTrials.gov registry record · NA
Predictive algoRithm for EValuation and Intervention in SEpsis
A NA study of Sepsis and Septic Shock, sponsored by Dascena.
- Completed
- Registry status
- NA
- Development phase
- 2,296
- Enrollment target
- 1
- Study location
NCT03235193: Completed NA study of Sepsis and Septic Shock, sponsored by Dascena.
NCT03235193 is a NA study of Sepsis and Septic Shock that has completed, run by Dascena. The registered enrollment target is 2,296 participants, below the 6,539-participant average among 90 other Sepsis trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03235193, a NA study of Sepsis and Septic Shock, has completed, sponsored by Dascena.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,296 participants
- Enrollment target
- 1
- Study location
Study Summary
In this prospective study, the ability of a machine learning algorithm to predict sepsis and influence clinical outcomes, will be investigated at Cabell Huntington Hospital (CHH).
Conditions Studied
Interventions
- OTHER Severe Sepsis Prediction
- OTHER Severe Sepsis Detection
Study Locations (1)
West Virginia
- Cabell Huntington Hospital - Huntington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,296 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2017-08-30 |
| Phase | NA |
What the finished NCT03235193 record still lists
NCT03235193 is an interventional study that assigns participants to a tested intervention. Its 2,296 participants enrollment target places it among the larger protocols in the corpus, below the 6,539-participant average among 90 other Sepsis trials with a reported enrollment target (65% lower).
The record links to 3 conditions, with Sepsis appearing as the primary indexed condition, and to 2 interventions - of which Severe Sepsis Prediction is the first listed.
NCT03235193 reports a single indexed study location in West Virginia.
Frequently Asked Questions
What is clinical trial NCT03235193 about?
NCT03235193 is a clinical study titled "Predictive algoRithm for EValuation and Intervention in SEpsis". In this prospective study, the ability of a machine learning algorithm to predict sepsis and influence clinical outcomes, will be investigated at Cabell Huntington Hospital (CHH).
What is the current status of trial NCT03235193?
This trial is currently completed. It is a NA study. The enrollment target is 2,296 participants. The study started on 2017-07-01. Estimated completion is 2017-08-30.
What conditions does trial NCT03235193 study?
This clinical trial studies the following conditions: Sepsis, Septic Shock, Severe Sepsis.
What interventions are being tested in trial NCT03235193?
The interventions under investigation include: Severe Sepsis Prediction (OTHER), Severe Sepsis Detection (OTHER).
Who is sponsoring clinical trial NCT03235193?
This trial is sponsored by Dascena, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03235193 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03235193's enrollment target sits among peer trials
2,296 15th of 90 higher than 76 of 90 other Sepsis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sepsis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
-
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
RECRUITING · NA
-
BLOOM: Pragmatic Feasibility Trial
RECRUITING · NA
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
-
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05530343 · 2,298 participants · NA
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- NCT04124120 · 2,300 participants · NA
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
- NCT05237258 · 2,300 participants · NA
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
- NCT05732623 · 2,300 participants
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI